The U.S. Food and Drug Administration has approved Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G ...

This approval offers a promising new targeted treatment for patients aged 12 and older with C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), ...

For three days inside the Charleston Convention Center, fire, EMS, law enforcement and dispatchers from the tri-county ...

I've been writing about the LG C3 OLED TV since its release in 2023, and it has consistently been a best-seller, thanks to ...

Apellis Pharmaceuticals has made pipeline progress and strengthened its balance sheet. Click here to read an analysis of APLS ...

BornHack is a week-long summer hacker camp in a forest on the Danish island of Fyn, that consistently delivers a very ...

Pirelli has nominated its tyre compounds for the remaining Formula 1 races of 2025, with some changes compared to its ...

Discover an unbeatable offer from CFAO Mobility: purchase the rugged Peugeot Landtrek 4x2 Double Cab and receive the stylish ...

A WELL-KNOWN Irish road is set to close to traffic for three days with diversions in place. Dublin City Council has alerted motorists about the temporary closure on their website. Hughes Road in ...

Will ticket stubs to the first three Soundside festivals now wind up collector's items of a blip in live music history? Or will the event return and thrive following the abrupt cancellation of this ...

Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.